Aravive, Inc. Profile Avatar - Palmy Investing

Aravive, Inc.

Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets…

Biotechnology
US, Houston [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Aravive, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Aravive, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Aravive, Inc..

End of ARAV's Analysis
CIK: 1513818 CUSIP: 03890D108 ISIN: US03890D1081 LEI: - UEI: -
Secondary Listings
ARAV has no secondary listings inside our databases.